
Lawsuits Are Being Considered By Heartburn Drug Cancer Victims
One by one, manufacturers of over the counter and prescription heartburn medication are recalling their products because they contain deadly amounts of a cancer-causing substance
Thursday, April 9, 2020 - Hundreds of lawsuits are being filed against, Sanofi, Boehringer Ingelheim Pharmaceuticals, and GlaxoSmithKline, the past and present makers of a popular anti-heartburn and antacid medication alleging that the regular, frequent, and long-term use of the drug to stop a condition commonly known as acid reflux, caused their cancer. In line with the litigation that is expected from individuals with various forms of heartburn drug cancer, the FDA is aggressively monitoring developments. On February 27, 2020, the FDA alerted patients and health care professionals to "American Health Packaging's voluntary recall of ranitidine tablets (150 mg), manufactured by Amneal Pharmaceuticals, LLC. The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA)." Attorneys representing families nationwide for Zantac heartburn medication cancer are offering a free consultation and no obligation to file a claim.
Bellwether trial dates are about to be scheduled and last week Daily Mail.co.uk published the story of a woman, Deborah Haskins, of Ridgeway, Virginia filing a lawsuit that alleges taking Zantac daily for years gave her cancer of the esophagus, the hollow passageway between the throat and the stomach. According to the Daily Mail, "Haskins is suing the drug's makers for batteary, for failing to warn consumers of the risks, committing fraud and having a design defect." Sanofi has admitted the drug's contamination and recalled over the counter Zantac and generic Zantac in October 2019. Since the recall drugstore chains including CVS and Walgreen have pulled Zantac and other generic versions of the heartburn drug ranitidine from store shelves. According to DM, the plaintiff has used the drug daily since 2005, however, there is no indication as to when she was first diagnosed with esophageal cancer. Haskin's lawsuit seeks an unknown amount for reimbursement of medical-related costs, loss of income, and loss of quality of life.
Esophageal cancer is a deadly and painful condition and like all cancer is best treated when diagnosed as early as possible. Cancer Center.com describes the early symptoms that anti-heartburn drug users should look out for as: "trouble swallowing, or dysphagia, that generally worsens over time. Unintentional weight loss. Chest pain or discomfort and hoarseness when speaking." Cancer.gov considers esophageal cancer as a condition that can in most case be managed if caught in its initial stages. "Esophageal cancer is a treatable disease, but it is rarely curable. The overall 5-year survival rate in patients amenable to definitive treatment ranges from 5% to 30%. The occasional patient with a very early disease has a better chance of survival."
N-nitrosodimethylamine (NDMA) is a carcinogen that is given to laboratory test animals to induce cancer. The connection between the substance and popular antacid brands was first discovered by drug testing company Valspar Pharmaceuticals, which warned the FDA that it had found dangerously high levels (three times the FDA limit) of " N-nitrosodimethylamine, or NDMA, a highly toxic carcinogen." Attorneys representing plaintiffs suing the drug manufacturers have stated that a 100-milligram tablet of Zantac 75 can be "the equivalent of smoking 30 packs of cigarettes."
More Recent Heartburn MedicineLawsuit News:
- The FDA Suspects Zantac Could Contain Five More Cancer-Causing Impurities | 3/6/2021
- The Department of Justice Points To a 1983 Study That Found Accelerated Levels of NDMA in ranitidine | 3/3/2021
- Zantac Remains Off Of Store Shelves More Than A Year After NDMA Contamination Was Discovered | 3/2/2021
- Vitamins Can Help Regulate Stomach Acid | 2/27/2021
- Online Pharmacy Can Fill Prescriptions After Testing Your Drugs For Purity and Safety | 2/22/2021
- Walmart And CVS Are Co-Defendants in Ranitidine (Zantac) Cancer Lawsuits | 2/17/2021
- More Ways To Alleviate Heartburn Pain With Zantac No Longer Available | 2/16/2021
- Gradual Lifestyle Changes Can Cure Heartburn And Acid Reflux Disease | 2/15/2021
- Purity Certification May Have To Be Met If Zantac Could Ever Be Sold Again | 2/10/2021
- Zantac Alternatives May Cause Serious Diseases | 2/9/2021
- Constant Use of Heartburn and Acid Reflux Drugs Like Zantac Could Double Cancer Risks | 2/5/2021
- Ranitidine Is Unstable According to Valisure | 2/2/2021
- Heartburn Sufferers Look To PPI Drugs To Control Acid Reflux Disease and GERD | 2/1/2021
- California Zantac Plaintiffs Want State Court To Hear Their Cases | 1/29/2021
- Zantac Cancer Issues Are Affecting People In Europe, Canada, and The United States | 1/28/2021
- Former Zantac Users Need To Exercise a Little Common Sense | 1/27/2021
- The FDA Did Not Follow-Up Test Zantac Until Too Late | 1/25/2021
- Estates of the Desceased Can File a Zantac Cancer Lawsuit | 1/21/2021
- Zantac Cancer Prompts FDA To Seek Answers | 1/20/2021
- People May Be Exposed To NDMA From Many Sources | 1/19/2021
- Valisure CEO Infers Ranitidine (Zantac) May Be Unstable And Degrade On Its Own | 1/18/2021
- The Types of Zantac Cancer Identified In Multidistrict Litigation | 1/13/2021
- Zantac Cancer Trials Consolidated In Federal Court | 1/10/2021
- Facts About Filing A Zantac Cancer Lawsuit | 1/8/2021
- Zantac Cancer Claims Organized In Florida Multi-District Litigation | 1/6/2021
- Sanofi Could Be Guilty Of Failing To Disclose the potential presence of N-Nitrosodimethylamine (NDMA) in Zantac | 1/5/2021
- Ranitidine Zantac Cancer Will Make Headlines in 2021 | 1/4/2021
- FDA Recall of Zantac Ranks As One Of The Most Important Human Health Developments of 2020 | 12/28/2020
- Zantac Users May Require Surgery To Repair A Valve In Their Esophagus | 12/23/2020
- Study Finds Ranitidine (Zantac) May Be Inherently Unstable | 12/21/2020
- CEO Testimony May Implicate China As The Source Of Zantac NDMA Contamination | 12/16/2020
- Lockdowns Are Causing Obesity Heartburn Medicines Are In Short Supply | 12/14/2020
- Zantac And Ranitidine Are Recalled And The Alternatives Are In Short Supply | 12/11/2020
- Potential Zantac Cancer Plaintiffs Should Organize Their Documents | 12/9/2020
- Zantac Lawsuits Point To An Array of Negligence By Sanofi | 12/7/2020
- Ranitidine Could Be Back On The Market In Canada If The Manufacturer Meets Certain Conditions | 12/4/2020
- Scientific Experts Hired By Plaintiffs May Uncover The Reason Zantac Allegedly Causes Cancer | 12/1/2020
- November Review of Important Zantac Cancer Developments | 11/25/2020
- Advice For Former Zantac Patients Now That The Heartburn Drug Is No Longer Available | 11/23/2020
- Potential Zantac Plaintiffs Must Provide A Record Of Using The Medine | 11/19/2020
- Nitrates Suspected To Have Caused Zantac Contamination | 11/18/2020
- Military Veterans May Be Developing More Zantac Cancer Than The General Population | 11/17/2020
- The Failure To Oversee Chinese Drug Manufacturing May Have Led To Zantac Cancer Contamination | 11/16/2020
- Surviving Spouses And The Children of Those Who Have Died From Cancer Are Filing Zantac Cancer Lawsuits | 11/10/2020
- Heartburn Management Centers Seek To Capitalize on Zantac Ban | 11/7/2020
- Recalls Accelerating For Heartburn, Blood Pressure, and Type 2 Diabetes Drugs Over Cancer Fears | 11/4/2020
- China And India Could Be The Source of Zantac Contamination | 11/2/2020
- Sanofi Under Criminal Investigation By The US Department of Justice For False Claims Act Violations | 10/29/2020
- Zantac Alternative Drugs Recommended By The FDA May Cause Memory Loss | 10/27/2020
- Scientists Focus On India And China As Source of Zantac Contamination | 10/26/2020
- Zantac May Cause Type-2 Diabetes As Well As Many Types of Cancer | 10/21/2020
- Discovery Proceeding in Zantac Cancer Litigation | 10/20/2020
- Heartburn Drug Manufacturer Sanofi Could Be Forced To Regularly Test Zantac For Carcinogens | 10/16/2020
- Researchers Continue to Struggle To Determine Why Zantac Could Cause Cancer | 10/12/2020
- Popular Zantac Alternative Drugs May Cause Type-2 Diabetes | 10/10/2020
- Tens Of Millions of Zantac Users May Develop Cancer | 10/7/2020
- Online Medical Experts Offer Advice On Dealing With Zantac Recall | 10/6/2020
- Sanofi May Have Known For Years That Zantac Could Cause Cancer | 10/5/2020
- Thousands of Former Zantac User Fear Cancer Diagnosis in Their Future | 10/1/2020
- Stomach Cancer Could Have Been Easily Treatable If Sanofi Warned of Zantac Cancer Sooner | 9/30/2020
- Administrative Procedures Organized in Lawsuits That Claim Zantac Caused Cancer | 9/28/2020
- Sanofi May Have Had An Obligation To Know That Zantac Could Cause Cancer | 9/24/2020
- Taking Zantac Was An Elective Decision Not A Medical Necessity | 9/23/2020
- Many Zantac Users Fear Stomach Cancer From Taking The Drug | 9/22/2020
- Many Zantac Users Fear Stomach Cancer From Taking The Drug | 9/21/2020
- Millions Were Left With Heartburn and Acid-Reflux Pain When Ranitidine (Zantac) Was Recalled | 9/17/2020
- Zantac Patients Are Advised Not To Abuse Their New PPI Drugs | 9/15/2020
- Plaintiffs Blame Zantac For Causing Colon Cancer | 9/14/2020
- Government Health Officials in The US and Canada Worry Zantac Cancer Could Affect Millions | 9/9/2020
- Zantac Prostate Cancer Has Men That Used Zantac Worried | 9/7/2020
- Zantac Cancer Contamination Could Occur In the Body | 8/31/2020
- Zantac Users Have Alternative Treatments That Diabetics and Others May Not | 8/29/2020
- Zantac Users Patiently Await Answers About Zantac Cancer | 8/26/2020
- Studies Find NDMA Increases For More Reasons Than High Temperatures Alone | 8/24/2020
- Understanding The Science of Zantac Breast Cancer | 8/15/2020
- Previous Zantac Users Should Make Lifestyle Changes | 8/12/2020
- Women Are Alarmed That Zantac May Cause Breast Cancer | 8/11/2020
- Removing Zantac From The Market Could Lead To People Developing Esophageal Cancer | 8/10/2020
- Alternative FDA Testing Methods Did Not Find Zantac To Be Dangerous | 8/6/2020
- An Online Testing Pharmacy May Have Jumped The Gun When Reporting Dangerous NDMA Levels | 8/5/2020
- Valisure's Testing Methods May Be Flawed And The Cause Of The Spike in NDMA | 8/3/2020
- Experts Are Trying To Understand NDMA | 7/31/2020
- Online Testing Pharmacy May Have Saved Millions From Zantac Cancer | 7/30/2020
- The FDA Falls Short in Zantac Cancer Testing | 7/28/2020
- Zantac Cancer May Be America's Next Public Health Crisis | 7/22/2020
- Cancer's Latency Could Drive Zantac Cancer Claims For Years | 7/20/2020
- Online Experts Warn Of The Dangers of Developing Zantac Cancer | 7/14/2020
- Zantac and Generic Ranitidine Heartburn Medicine Recalled Because of Cancer Link | 7/13/2020
- Former Zantac Users Have Few Options Left Other Than Adopting a Healthy Lifestyle | 7/10/2020
- Zantac Alternative Medicines May Increase The Risk of Contracting The Coronavirus | 7/8/2020
- Cases Are Being Consolidated Against Sanofi By Alleged Zantac Cancer Sufferers | 7/7/2020
- Zantac Users Should Consider Safer Alternative Drugs | 7/1/2020
- Nitrosamines NDMA Levels in Zantac Found To Be Thousands of Time Higher Than Acceptable | 6/30/2020
- The Zantac Cancer Scare Is Leading To Other Drug Recalls Throughout North America | 6/29/2020
- The Legal Process Has Started To Grind Against Heartburn Drug Manufacturers and Others | 6/24/2020
- Zantac Users Left Without Heartburn Medication By The Drugs Recalls | 6/22/2020
- Updated Guidance From The FDA Regarding Ranitidine, Zantac | 6/18/2020
- Diabetic Patients That Stop Taking Metformin Could Face Serious Health Complications | 6/16/2020
- Canada Follow The US And Recalls Several Diabetes Medications Over Cancer Risk | 6/15/2020
- It Has Been One Year Since Researchers Found a Carcinogen In Blood Pressure Medicine | 6/11/2020
- Finding Cancer Causing Chemicals in Heartburn Drugs Like Zantac May Be Only The Beginning | 6/10/2020
- Every Day Another Company Recalls Their Blood Pressure, Heartburn, or Diabetes Drug Due to Cancer Concerns | 6/8/2020
- Zantac Cancer May Be The Impetus Needed To Bring The US Drug Manufacturing Supply Chain Home | 6/5/2020
- Heartburn, Diabetes, and Blood Pressure Drugs May Contain Dangerously High Levels of a Carcinogen Called NDMA | 6/4/2020
- The FDA Is Forcing Some Diabetic Drug Manufacturers to Pull Their Type 2 Products From Store Shelves | 6/1/2020
- The FDA May Require Stricter Regulation of Foreign Drug Manufacturers | 5/29/2020
- Former Zantac Users Should Watch For Gastro-Intestinal Cancer Symptoms | 5/28/2020
- Lawsuits Continue To Be Filed Claiming Zantac Causes Cancer | 5/26/2020
- Global Concerns Over Zantac Cancer | 5/19/2020
- Breast Cancer Is The Latest Disease Allegedly Caused By Zantac | 5/18/2020
- Medical Expert Opinions Are Mixed About Zantac Being Carcinogenic | 5/12/2020
- Pepcid Anti-Heartburn Drug Sought To Treat Covid19 | 5/8/2020
- Heartburn Drugs May Be In Short Supply At Local Pharmacy | 5/6/2020
- FDA Recommended Heartburn Drugs May Cause Kidney Failure and Osteoperosis | 5/5/2020
- Zantac Users May Want to be Checked For Gastro-Intestinal Cancers | 5/1/2020
- Despite Zantac's Recall Other Antacid Medication Offer Promise To Help Alleviate COVID19 | 4/28/2020
- Zantac is Blamed For Causing Gastric Cancer | 4/23/2020
- Zantac Users Should Hold On To or Mail Back Unused Portions Instead Of Physically Returning The Drug | 4/20/2020
- Expert Advice For Previously Heavy Zantac Users | 4/16/2020
- Making Simple Dietary Changes Can Replace The Need For Antacids | 4/15/2020
- Lawsuit Alleges Zantac Caused Plaintiff's Colon Cancer | 4/13/2020
- Cancer-Causing Compound Leads to Diabetes Drug Recalls | 4/10/2020
- Lawsuits Have Been Filed After Tests Show Triple the Allowable Levels of NDMA in Antacid drugs | 4/8/2020
- Popular Over-The-Counter Heartburn Pills May Cause Stomach Cancer | 4/7/2020
- Popular Anti-acid Drugs May Contain a Compound That is Proven To Cause Cancer | 4/6/2020
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.